New study tests Scope-Based lesion removal in western patients

NCT ID NCT02989818

Recruiting now Knowledge-focused Sponsor: University of Florida Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is tracking 300 adults who are already scheduled to have a procedure called endoscopic submucosal dissection (ESD) to remove abnormal growths in their digestive tract. Researchers want to see how often the lesion can be removed in one piece with clear margins, and how safe the procedure is. The goal is to gather real-world evidence on whether ESD works well in Western patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Endoscopic submucosal dissection (ESD) procedure
What this could lead to: If successful, this study could confirm that ESD is a safe and effective standard technique for removing early gastrointestinal lesions in Western patients, potentially reducing the need for more invasive surgery.
What could go wrong: This is an observational study, not a randomized trial, so it cannot prove ESD is better than other methods. Results may vary across centers and patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENDOSCOPIC SUBMUCOSAL DISSECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ENDOSCOPIC SUBMUCOSAL DISSECTION

Contacts and locations

Locations

Baylor College of Medicine
RECRUITING

Houston, Texas, 77030, United States
Massachusetts General Hospital
RECRUITING

Boston, Massachusetts, 02114, United States
University of Florida
RECRUITING

Gainesville, Florida, 32610, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.